Endo International plc’s Par Pharmaceutical has begun shipping the first generic version of Merz's Cuvposa (glycopyrrolate) 1mg/5ml oral solution in the US, after earlier receiving US Food and Drug Administration approval for the product with 180-day exclusivity.
Citing IQVIA data, Endo said that Cuvposa sales were approximately $27m for the 12 months ended 31 October 2021. Cuvposa...




